Machida Yuka, Murata Shiro, Matsuyama-Kato Ayumi, Isezaki Masayoshi, Taneno Akira, Sakai Eishi, Konnai Satoru, Ohashi Kazuhiko
Department of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University, Kita-18, Nishi-9, Kita-ku, Sapporo 060-0818, Japan.
J Vet Med Sci. 2017 Jan 20;79(1):115-122. doi: 10.1292/jvms.16-0329. Epub 2016 Oct 8.
Gallid herpesvirus 2 (GaHV-2) causes malignant lymphomas in chickens (Marek's disease, MD). Although MD is controlled through vaccination efforts, field isolates of GaHV-2 have increased in virulence worldwide and even cause MD in vaccinated chickens. GaHV-2 strains are classified into four categories (mild, virulent, very virulent and very virulent +) based on the virulence exhibited in experimental infection in unvaccinated or MD-vaccinated susceptible chickens. Although MD cases are sporadically reported in Japan, the recent field strains of GaHV-2 in Japan have not been characterized. During isolation of recent field strains by using primary chicken kidney cell cultures, a method classically used for GaHV-2 isolation, vaccine strains were simultaneously isolated. Therefore, it is necessary to separate vaccine strains to characterize the virulence and pathogenicity of the GaHV-2 strains currently distributed in Japan. In this study, we prepared cell suspensions from the spleens of MD-symptomatic chickens, inoculated day-old-chicks and isolated GaHV-2 strains by primary chicken kidney cell cultures at 2-3 weeks post inoculation. The isolated strains were passaged several times on chicken embryo fibroblast cells, and PCR analysis revealed that the isolated strains were not contaminated with vaccine strains. Moreover, the contaminant vaccine strains were completely removed by the purification of plaques observed in chicken kidney cells. These procedures are necessary to isolate GaHV-2 field strains from vaccine strains in order to carry out future studies to characterize these strains and glean insights into GaHV-2 virulence and pathogenicity.
鸡疱疹病毒2型(GaHV-2)可引发鸡的恶性淋巴瘤(马立克氏病,MD)。尽管通过疫苗接种努力控制了马立克氏病,但GaHV-2的野外分离株在全球范围内毒力增强,甚至能使接种疫苗的鸡感染马立克氏病。根据在未接种疫苗或接种马立克氏病疫苗的易感鸡的实验性感染中表现出的毒力,GaHV-2毒株被分为四类(温和型、强毒型、超强毒型和超强毒+型)。尽管日本偶尔有马立克氏病病例报告,但日本近期的GaHV-2野外毒株尚未得到鉴定。在用经典的用于GaHV-2分离的原代鸡肾细胞培养物分离近期野外毒株的过程中,同时分离出了疫苗毒株。因此,有必要分离疫苗毒株,以鉴定目前在日本传播的GaHV-2毒株的毒力和致病性。在本研究中,我们从有马立克氏病症状的鸡的脾脏制备细胞悬液,接种一日龄雏鸡,并在接种后2至3周通过原代鸡肾细胞培养物分离GaHV-2毒株。分离出的毒株在鸡胚成纤维细胞上传代数次,PCR分析表明分离出的毒株未被疫苗毒株污染。此外,通过纯化在鸡肾细胞中观察到的噬斑,完全去除了污染的疫苗毒株。为了开展未来研究以鉴定这些毒株并深入了解GaHV-2的毒力和致病性,从疫苗毒株中分离GaHV-2野外毒株,这些步骤是必要的。